| An all-oral 6-month regimen for multidrug-resistant tuberculosis: a multicenter, randomized controlled clinical trial (the NExT study) A Esmail, S Oelofse, C Lombard, R Perumal, L Mbuthini, ... American Journal of Respiratory and Critical Care Medicine 205 (10), 1214-1227, 2022 | 82 | 2022 |
| Bedaquiline microheteroresistance after cessation of tuberculosis treatment M De Vos, SD Ley, KB Wiggins, B Derendinger, A Dippenaar, ... New England Journal of Medicine 380 (22), 2178-2180, 2019 | 61 | 2019 |
| Diagnostic accuracy and utility of FluoroType MTBDR, a new molecular assay for multidrug-resistant tuberculosis M de Vos, B Derendinger, T Dolby, J Simpson, PD van Helden, JE Rice, ... Journal of clinical microbiology 56 (9), 10.1128/jcm. 00531-18, 2018 | 49 | 2018 |
| Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study B Derendinger, A Dippenaar, M de Vos, S Huo, R Alberts, R Tadokera, ... The Lancet Microbe 4 (12), e972-e982, 2023 | 24 | 2023 |
| Comparative diffusion of drugs through bronchial tissue JM van Zyl, B Derendinger, HI Seifart, P Van der Bijl International journal of pharmaceutics 357 (1-2), 32-36, 2008 | 18 | 2008 |
| Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping R Venter, B Derendinger, M De Vos, S Pillay, T Dolby, J Simpson, ... Scientific reports 7 (1), 14854, 2017 | 17 | 2017 |
| Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the … A Gupta-Wright, H Ha, S Abdulgadar, R Crowder, J Emmanuel, ... The Lancet Global Health 12 (2), e226-e234, 2024 | 15 | 2024 |
| Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and … A Dippenaar, B Derendinger, T Dolby, N Beylis, PD van Helden, G Theron, ... Clinical Microbiology and Infection 27 (9), 1351. e1-1351. e4, 2021 | 15 | 2021 |
| Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment SB Georghiou, TC Rodwell, A Korobitsyn, SH Abbadi, K Ajbani, ... European Respiratory Journal 59 (4), 2022 | 13 | 2022 |
| Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring S Huddart, L Asege, D Jaganath, M Golla, H Dang, L Lovelina, ... The International Journal of Tuberculosis and Lung Disease 27 (3), 221-222, 2023 | 11 | 2023 |
| Widespread use of incorrect PCR ramp rate negatively impacts multidrug-resistant tuberculosis diagnosis (MTBDRplus) B Derendinger, M De Vos, RR Nathavitharana, T Dolby, JA Simpson, ... Scientific reports 8 (1), 3206, 2018 | 10 | 2018 |
| Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross … BWP Reeve, G Ndlangalavu, H Mishra, Z Palmer, H Tshivhula, ... The Lancet Global Health 12 (5), e793-e803, 2024 | 7 | 2024 |
| Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross … R Venter, S Minnies, B Derendinger, H Tshivhula, M De Vos, T Dolby, ... Scientific Reports 10 (1), 2633, 2020 | 7 | 2020 |
| Non-actionable Results, Accuracy, and Effect of First-and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a … S Pillay, M de Vos, B Derendinger, EM Streicher, T Dolby, LA Scott, ... Clinical Infectious Diseases 76 (3), e920-e929, 2023 | 6 | 2023 |
| Detection of second line drug resistance among drug resistant Mycobacterium tuberculosis isolates in Botswana T Mogashoa, P Melamu, B Derendinger, SD Ley, EM Streicher, T Iketleng, ... Pathogens 8 (4), 208, 2019 | 6 | 2019 |
| Frequent suboptimal thermocycler ramp rate usage negatively impacts GenoType MTBDRsl VER 2.0 performance for second-line drug-resistant tuberculosis diagnosis B Derendinger, M de Vos, S Pillay, R Venter, J Metcalfe, Y Ghebrekristos, ... The Journal of Molecular Diagnostics 24 (5), 494-502, 2022 | 3 | 2022 |
| An independent, multi-country head-to-head accuracy comparison of automated chest x-ray algorithms for the triage of pulmonary tuberculosis W Worodria, R Castro, SV Kik, V Dalay, B Derendinger, C Festo, ... medRxiv, 2024.06. 19.24309061, 2024 | 2 | 2024 |
| Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation YT Ghebrekristos, N Beylis, CM Centner, R Venter, B Derendinger, ... The Lancet Microbe 4 (10), e822-e829, 2023 | 2 | 2023 |
| C-reactive protein-based tuberculosis triage testing: a multi-country diagnostic accuracy study B Derendinger, TK Mochizuki, D Marcelo, D Shankar, W Mangeni, ... medRxiv, 2024 | 1 | 2024 |
| Melting the eis: Nondetection of Kanamycin Resistance Markers by Routine Diagnostic Tests and Identification of New eis Promoter Variants SD Ley, S Pillay, EM Streicher, YF van der Heijden, F Sirgel, ... Antimicrobial Agents and Chemotherapy 65 (7), 10.1128/aac. 02502-20, 2021 | 1 | 2021 |
Robin M WarrenStellenbosch UniversityVerified email at sun.ac.za
